| Certification: | ISO, HACCP, Kosher Halal |
|---|---|
| Assay Method: | HPLC, UV, Tlc Gc |
| Application Form: | Tablet, Capsule, Pills,Softgel |
| Application: | Food, Health Care Products, Medicine, Cosmetics,Supplement,Beverage, Nutrition,Pharma |
| State: | Powder |
| Extract Source: | Leaf |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Melaleuca Extract
Product Name: Melaleuca Extract
Latin Name: Melaleuca leucadendron L
Plant Source: Leaf
Specification: 5:1,10:1,50:1
Appearance: Yellow Brown Powder
Test Method: TLC
Description:
Huperzia serrata is luxuriant plants, it has the total of eight varieties of medicinal plants in China.This species
is native to India and southeast Asia.Huperzine A is a naturally occurring sesquiterpene alkaloid compound
found in the firmoss Huperzia serrata.Huperzine A has been found, through multiple studies, to be effective
as a medicine for helping people with neurological conditions such as Alzheimer's disease.Huperzine A is
also marketed as a dietary supplement with claims made for its ability to improve memory and mental function.
Huperzine A may also have a possible role in the treatment of myasthenia gravis.
Certificate of Analysis:
| Item | Specification | Results | Methods |
| Maker Compound | 10:1 | Conform | TLC |
| Appearance & Color | Yellow Brown Powder | Conform | GB5492-85 |
| Odor & Taste | Characteristic | Conform | GB5492-85 |
| Plant Part Used | Leaf | Conform | |
| Extract Solvent | Water & Ethanol | Conform | |
| Bulk Density | 0.4-0.6g/ml | 0.48g/ml | |
| Mesh Size | 80 | 100% | GB5507-85 |
| Loss on Drying | ≤5.0% | 3.50% | GB5009.3 |
| Ash Content | ≤5.0% | 2.79% | GB5009.4 |
| Solvent Residue | Negative | Conform | GC(2005 E) |
| Heavy Metals | |||
| Total Heavy Metals | ≤10ppm | <3ppm | AAS |
| Arsenic (As) | ≤1.0ppm | <0.5ppm | AAS(GB/T5009.11) |
| Lead (Pb) | ≤1.5ppm | <0.5ppm | AAS(GB5009.12) |
| Cadmium | <1.0ppm | Not Detected | AAS(GB/T5009.15) |
| Mercury | ≤0.1ppm | Not Detected | AAS(GB/T5009.17) |
| Microbiology | |||
| Total Plate Count | ≤10000cfu/g | <1000cfu/g | GB4789.2 |
| Total Yeast & Mold | ≤1000cfu/g | <100cfu/g | GB4789.15 |
| E. Coli | ≤40MPN/100g | Not Detected | GB/T4789.3-2003 |
| Salmonella | Negative in 25g | Not Detected | GB4789.4 |
| Staphylococcus | Negative in 10g | Not Detected | GB4789.1 |
| Packing and Storage | 25kg/drum Inside: Double-deck plastic bag, outside: Neutral cardboard barrel & Leave in the shady and cool dry place | ||
| Shelf Life | 3 Year When Stored properly | ||
| Expiration Date | 3 Year | ||
Function:
1. It is used to treat and improve the memory impairment of middle-aged and elderly people and improve
the associative memory function; It is used to reduce memory caused by excessive use of brain and improve
learning and work efficiency;
2. It is used for memory impairment associated with neurasthenia;
3. Huperzine A is used for memory loss caused by cerebrovascular disorders;
4. It is used to improve the memory of Alzheimer's disease, which has obvious curative effect on improving
and restoring the cognitive and memory function of patients and improving the abnormal emotional behavior;
5. For the treatment of myasthenia gravis;
6. Huperzine A can improve the association disorder, cognitive impairment and memory loss associated
with schizophrenia;
7. It can improve the memory impairment associated with a variety of brain diseases and somatic diseases.
1. As pharmaceutical raw materials for memory impaired cognitive function and emotional behavior;
2. As the raw material of product for Improving memory, thinking;
3. Can be used in the treatment of myasthenia gravis.
Good Comments:
Packing:
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}